Correlation between elevated intratumoral thymidine phosphorylase and prognosis of node-positive breast carcinoma undergoing adjuvant doxifluridine treatment.

International journal of oncology

Volumn 17, Issue 6, 2000, Pages 1205-1211

  Takahashi, H ^a   Maeda, Y ^a   Watanabe, K ^a   Taguchi, K ^a   Sasaki, F ^a   Todo, S ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DOXIFLURIDINE; ENZYME INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR; FLOXURIDINE; PROGESTERONE; PROGESTERONE RECEPTOR; THYMIDINE PHOSPHORYLASE; TUMOR PROTEIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; DISEASE FREE SURVIVAL; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; HUMAN; LIFE TABLE; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PAGET NIPPLE DISEASE; PROGNOSIS; PROTO ONCOGENE; SURVIVAL;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ENZYME INHIBITORS; ESTROGENS; FEMALE; FLOXURIDINE; GENES, ERBB-2; HUMANS; LIFE TABLES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROGESTERONE; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE;

MLCS; MLOWN;

EID: 0034546819     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.17.6.1205     Document Type: Article

References (0)